MC1271A1 - Procede d'obtention d'un agent anti-tumoral - Google Patents

Procede d'obtention d'un agent anti-tumoral

Info

Publication number
MC1271A1
MC1271A1 MC791396A MC1396A MC1271A1 MC 1271 A1 MC1271 A1 MC 1271A1 MC 791396 A MC791396 A MC 791396A MC 1396 A MC1396 A MC 1396A MC 1271 A1 MC1271 A1 MC 1271A1
Authority
MC
Monaco
Prior art keywords
sarcosine
tumor
dose
series
combination
Prior art date
Application number
MC791396A
Other languages
English (en)
French (fr)
Inventor
Osswald Hans
Youssef Mahmoud
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of MC1271A1 publication Critical patent/MC1271A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MC791396A 1978-07-20 1979-07-19 Procede d'obtention d'un agent anti-tumoral MC1271A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782832009 DE2832009A1 (de) 1978-07-20 1978-07-20 Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Publications (1)

Publication Number Publication Date
MC1271A1 true MC1271A1 (fr) 1980-05-23

Family

ID=6044955

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791396A MC1271A1 (fr) 1978-07-20 1979-07-19 Procede d'obtention d'un agent anti-tumoral

Country Status (13)

Country Link
US (1) US4766149A (enExample)
EP (1) EP0007597B1 (enExample)
JP (1) JPS5519270A (enExample)
AT (1) ATE11220T1 (enExample)
AU (1) AU529657B2 (enExample)
CA (1) CA1151065A (enExample)
DD (1) DD144864A5 (enExample)
DE (1) DE2832009A1 (enExample)
DK (1) DK305479A (enExample)
FI (1) FI792218A7 (enExample)
MC (1) MC1271A1 (enExample)
NO (1) NO792398L (enExample)
ZA (1) ZA793603B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
US4994492A (en) * 1989-01-09 1991-02-19 Foodscience Corporation Treatment of melanoma using N,N-dimethylglycine
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
DE4026184A1 (de) * 1990-08-18 1992-02-20 Henkel Kgaa Verfahren zur verminderung des restgehaltes an freiem alkylierungsmittel in waessrigen loesungen kationischer tenside
BRPI0311909A8 (pt) * 2002-06-19 2018-02-06 Nutricia Nv Métodos para a manufatura de uma composição, e para aumentar a capacidade de metilação de um indivíduo, e, composição farmacêutica ou nutricional
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1847274A1 (en) * 2006-04-21 2007-10-24 CIPROSA LLC - Corporate Creations Network, Inc. Association of phenylbutyrate, ATRA and cytidine and its use in anti-tumour therapy
EP3415910A1 (en) 2017-06-16 2018-12-19 Prevention Medicals s.r.o. A method of quantitative determination of sarcosine in a biological sample using anti-arcosine antibodies and peroxidase-active gold nanoparticles or quantum dots

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE553424C (de) * 1928-04-18 1932-06-27 Karl Luedecke Dr Verfahren zur Herstellung von Praeparaten, die das Wachstum von Geweben durch Verminderung der Teilungsfaehigkeit oder Aufloesung der wuchernden Zellen einschraenken
BE647556A (enExample) * 1964-05-06 1964-08-31
FR2085637A1 (fr) * 1970-04-15 1971-12-31 Etude Des Catalyseurs Soc D Composition pharmaceutique utilisable notamment contre l'asthenie
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline

Also Published As

Publication number Publication date
CA1151065A (en) 1983-08-02
NO792398L (no) 1980-01-22
DD144864A5 (de) 1980-11-12
DE2832009A1 (de) 1980-01-31
US4766149A (en) 1988-08-23
AU529657B2 (en) 1983-06-16
FI792218A7 (fi) 1981-01-01
AU4907679A (en) 1980-01-24
JPS5519270A (en) 1980-02-09
DK305479A (da) 1980-01-21
EP0007597B1 (de) 1985-01-16
ZA793603B (en) 1980-07-30
EP0007597A1 (de) 1980-02-06
ATE11220T1 (de) 1985-02-15
DE2832009C2 (enExample) 1988-07-28

Similar Documents

Publication Publication Date Title
MC1271A1 (fr) Procede d'obtention d'un agent anti-tumoral
EP1295597A1 (fr) Compositions antitumorales contentant des derives du taxane
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
EP2958569B1 (fr) Hétérocycles phosphorés analogues de sucres à activité antimétastatique
LU86403A1 (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers
WO1993010792A1 (fr) Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs
EP0280593B1 (fr) Composition à base d'acide aminé et de vitamines utilisable en thérapeutique cancérologique
FR2620450A1 (fr) Nouveaux sels de composes organogermaniques et medicaments les contenant
CN111201018A (zh) 用于治疗与改变的tca循环代谢相关的病状的组合物和方法
EP2362772B1 (fr) Association pharmaceutique contenant l'acide lipoïque et l'acide hydroxycitrique a titre de principes actifs
FR2538385A1 (fr) Composes enamides acyles, compositions pharmaceutiques les contenant, utilisation de ces composes et procede de preparation de ces composes
EP0108017B1 (fr) Association renfermant à titre de principes actifs, un analgésique central et la vitamine B12 ou un de ses analogues
EP0470144B1 (fr) D-acide aspartique beta-hydroxamate pour le traitement des infections virales et des tumeurs
EP0986390B1 (fr) Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine
FR2986796A1 (fr) Methodes et compositions pour le traitement du cancer
CA2968483A1 (fr) Derives hydroxybisphosphoniques hydrosolubles de la doxorubicine
FR2516085A1 (fr) Sels quaternaires de n,n3-di(b-bromopropionyl)-n1,n2-dispirotripiperazinium, procede de preparation desdits sels et medicament a action antitumorale a base d'un tel sel
US5736530A (en) Guanylic acid derivatives and their use as drugs
FR2572934A1 (fr) Compositions pharmaceutiques hydrosolubles a base de sels de l'acide (-)cis-1,2-epoxypropylphosphonique avec des amino-acides
WO1984004249A2 (fr) Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires
FR2461725A1 (en) Mono and bis di:isopropylamine serine-phosphate(s) - are peripheral vasodilators and antiparkinson agents
WO1992008458A1 (en) Use of temocillin or carbenicillin for the treatment or prophylaxis of bacterial infections in fish
LU87274A1 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes
HK1138774A1 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
YP Annual fee paid